These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 90060)

  • 41. Anti-HLA-B7,B27,Bw42,Bw54,Bw55,Bw56, Bw67,Bw73 monoclonal antibodies: specificity, idiotypes, and application for a double determinant immunoassay.
    Sakaguchi K; Ono R; Tsujisaki M; Richiardi P; Carbonara A; Park MS; Tonai R; Terasaki PI; Ferrone S
    Hum Immunol; 1988 Mar; 21(3):193-207. PubMed ID: 3259570
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic implications of HLA and disease associations.
    Bias WB; Chase GA
    Transplant Proc; 1977 Mar; 9(1):531-42. PubMed ID: 68587
    [No Abstract]   [Full Text] [Related]  

  • 43. Monoclonal antibodies against two separate alloantigenic sites of HLA-B40.
    Parham P
    Immunogenetics; 1981; 13(6):509-27. PubMed ID: 7026428
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The binding of monoclonal antibodies to cell surface molecules. Quantitative analysis of the reactions and cross-reactions of an antibody (MB40.3) with four HLA-B molecules.
    Parham P
    J Biol Chem; 1984 Nov; 259(21):13077-83. PubMed ID: 6333424
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Common antigenic structures of HL-A antigens. VI. Common antigenic determinants located on the 33,000 Dalton alloantigenic fragment portion of papain-solubilized HL-A molecules.
    Nakamuro K; Tanigaki N; Pressman
    Immunology; 1975 Dec; 29(6):1119-32. PubMed ID: 53197
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cross-reactivity of anti-DRw sera evaluated by serologic studies on established B-lymphoid cell lines.
    Antonelli P; Kamoun M; Hansen JA; Dupont B
    Transplant Proc; 1978 Dec; 10(4):849-51. PubMed ID: 83719
    [No Abstract]   [Full Text] [Related]  

  • 47. The transient HLA antigenic loss dependent on hormonal state of organism in a healthy woman.
    Májsky A; Jakoubková J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(2):237-41. PubMed ID: 69587
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antigenic determinants of the HLA-B7 molecule; Bw6- and B7-specific determinants are spatially separate.
    Parham P
    Immunogenetics; 1983; 18(1):1-16. PubMed ID: 6190743
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A complex of HLA-D specificities detected by HTC typing: Dw7, Dw11, and TMo.
    Stastny P
    Transplant Proc; 1978 Dec; 10(4):759-61. PubMed ID: 83707
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A transposable epitope of HLA-B7, B40 molecules.
    Ways JP; Lawlor DA; Wan AM; Parham P
    Immunogenetics; 1987; 25(5):323-8. PubMed ID: 2437025
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential behavior of cytotoxic effector cells against HLA antigens in strong genetic linkage disequilibrium.
    Kim SJ; Christiansen FT; Silver DM; Dupont B
    Immunogenetics; 1981; 13(4):297-309. PubMed ID: 6168580
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The monoclonal xenoantibody Q6/64 recognizes a determinant expressed by certain gene products of the A and B loci of the HLA region.
    Quaranta V; Pellegrino MA; Ferrone S
    Immunogenetics; 1981; 14(5):403-13. PubMed ID: 6174438
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of two distinct public specificities on HLA-A28 bearing lymphocytes.
    Oldfather JW; Gebel HM; Holmes DJ; Rodey GE
    Tissue Antigens; 1983 Jul; 22(1):16-23. PubMed ID: 6193603
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Many genes, many clinical features.
    Brewerton DA
    Ann Rheum Dis; 1979; 38 Suppl 1(Suppl 1):suppl 145-8. PubMed ID: 318100
    [No Abstract]   [Full Text] [Related]  

  • 55. Nucleotide sequence analysis of HLA-B*1523 and B*8101. Dominant alpha-helical motifs produce complex serologic recognition patterns for the HLA-B"DT" and HLA-B"NM5" antigens.
    Ellexson ME; Zhang G; Stewart D; Lau M; Teresi G; Terasaki P; Roe B; Hildebrand W
    Hum Immunol; 1995 Oct; 44(2):103-10. PubMed ID: 8847228
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The inclusion of HLA-Bw42, Bw54 and Bw55 within the HLA-B14 cross-reactive group.
    Darke C
    Tissue Antigens; 1983 Mar; 21(3):246-53. PubMed ID: 6190262
    [No Abstract]   [Full Text] [Related]  

  • 57. Cross-reactivity between human and murine lymphocyte antigens. IV. Reactivity of H-2 alloantisera with HLA-A, B antigens.
    Quaranta V; Pellegrino MA; Callahan GN; Ferrone S
    Immunogenetics; 1981; 13(4):311-7. PubMed ID: 6168581
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Primary structure of papain-solubilized human histocompatibility antigen HLA-B40 (-Bw60). An outline of alloantigenic determinants.
    López de Castro J; Bragado R; Strong DM; Strominger JL
    Biochemistry; 1983 Aug; 22(16):3961-9. PubMed ID: 6193808
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of fresh serum obtained from baby, young, and mature rabbits on the specificity and cross-reactivity of HLA reactions.
    Cannady WG; Martin SL; Yunis EJ; Inbar M
    Transplant Proc; 1978 Dec; 10(4):729-34. PubMed ID: 83706
    [No Abstract]   [Full Text] [Related]  

  • 60. [Human leukocytic antigens (HL-A) and diseases].
    Tananov AT
    Probl Gematol Pereliv Krovi; 1978 Mar; 23(3):45-50. PubMed ID: 77014
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.